A subscription to JoVE is required to view this content. Sign in or start your free trial.
Not Published
This protocol describes asynchronous mixing of human embryonic stem cells derived kidney progenitors at the air-liquid interface to efficiently generate kidney organoids.
The prevalence of kidney diseases continues to increase worldwide, driving the need to develop transplantable renal tissues. The kidney develops from four major renal progenitor populations: nephron epithelial, ureteric epithelial, interstitial and endothelial progenitors. Methods have been developed to generate kidney organoids but few or dispersed tubular clusters in the organoids hamper its use in regenerative applications. Here, we describe a detailed protocol of asynchronous mixing of kidney progenitors using organotypic culture conditions to generate kidney organoids tightly packed with tubular clusters and major renal structures including endothelial network and functional proximal tubules. This protocol provides guidance in the culture of human embryonic stem cells and their directed differentiation to kidney organoids. Our 18-day protocol provides a rapid method to generate kidney organoids that facilitate the study of different nephrological events including in-vitro tissue development, disease modeling and chemical screening. However, further studies are required to optimize the protocol to generate additional renal-specific cells types, interconnected nephron segments and physiologically functional renal tissues.
Chronic kidney disease (CKD) is a worldwide healthcare problem with 13.4% global estimated prevalence1. Approximately 10% of the adult population of the United States suffers from CKD2. There is no curative treatment available for patients with CKD except renal transplantation. The lack of availability of transplantable organs warrants research into technologies to understand how new kidney tissues can be generated. In recent years, procedures have been reported to generate kidney organoids3,4 from human embryonic stem cells (hESCs) and human induced pluripotent ....
Cell line WA09 (H9) was approved by the National Institutes of Health (registration number 0062) and was tested negative for mycoplasma infection.
1. Medium and plate preparation for hESCs culture
This protocol describes asynchronous mixing of kidney progenitor cells differentiated from hESCs (H9) at the air-liquid interface to generate kidney organoids with reproducible results and high success rates. We followed a previously published protocol to differentiate hESCs into kidney progenitors3 (Figure 1). The mix of cells that arises from the directed differentiation process is believed to represent the repertoire of developmental kidney progenitors that gives r.......
Asynchronous mixing of progenitors at the air-liquid interface (Figure 1) presents an efficient method to generate kidney organoids from hESCs. This work describes stepwise protocols for thaw and culture of hESCs, directed differentiation to kidney progenitors, making cell aggregates at the air-liquid interface, asynchronous mixing of progenitors to generate kidney organoids tightly packed with tubular clusters and major renal structures including endothelial network and functional proximal .......
This work was supported in part by Merit Review Award #I01 BX002660 from the United States Department of Veterans Affairs, Biomedical Laboratory Research and Development Service to Jason A. Wertheim, National Institutes of Health grant number R24 DK106743 to Leif Oxburgh and National Institute of Diabetes and Digestive and Kidney Diseases award number F30DK123985 and National Institute of General Medical Sciences award number T32GM008152 to Bilal A. Naved. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Department of Veterans Affairs, or the Unit....
Name | Company | Catalog Number | Comments |
15 mL falcon tube | VWR | 62406-200 | |
24 well plate | VWR | 29443-952 | |
40 micron strainer | VWR | 21008-949 | |
50 mL falcon tube | VWR | 21008-940 | |
6 well plate | VWR | 29442-042 | |
96 well Clear Round Bottom Ultra-Low Attachment Microplate (U bottom) | Corning | 7007 | |
Accutase | STEMCELL Technologies | 7920 | Store at -20 °C |
Activin A | R&D systems | 338-AC-010 | Aliquot and store at -20 °C |
Advanced RPMI 1640 | ThermoFisher Scientific | 12633-012 | Store at 4 °C |
APEL2 | STEMCELL Technologies | 5270 | Store at -20 °C |
BMP7 | R&D systems | 354-BP-010 | Aliquot and store at -20 °C |
CHIR99021 IN SOLUTION | Reprocell | 04-0004-10 | Aliquot and store at -20 °C |
Confocal microscope | Leica Microsystems | SP8 | |
Dextran, AF 488, 10,000 MW | Thermo fisher Scientific | D22910 | Store at -20 °C |
DMEM/F12 | Thermo fisher Scientific | 11330-032 | Store at 4 °C |
DPBS | VWR | 45000-434 | |
FBS | Atlanta Biologicals | S11550 | Store at -20 °C |
FGF2 | R&D systems | 234-FSE-025 | Aliquot and store at -20 °C |
FGF9 | R&D systems | 273-F9-025 | Aliquot and store at -20 °C |
Forceps | Roboz | RS-5040 | |
Geltrex | Thermo fisher Scientific | A1413301 | Aliquot and Store at -20 °C |
Glutamax | Thermo fisher Scientific | 35050061 | |
H9 cells | WiCell | WA09 | Store in liquid Nitrogen |
Heparin | Sigma | H3393-25KU | |
Isopore membrane | EMD Millipore | VCTP01300 | |
Paraformaldehyde | P6148-500G | P6148-500G | |
PFHM II | Thermo fisher Scientific | 12040077 | Store at 4 °C |
Rock inhibitor Y-27632 | EMD Millipore | 688002-1mg | Aliquot and store at -20 °C |
StemFit Medium | amsbio | SFB-500 | Store at -20 °C |
Triton X-100 | Sigma | X100-100ML | |
TrypLe express | Thermo fisher Scientific | 12563029 |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved